Autopsy report · NCT04432103

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

“There is new evidence that the Convalescent plasma is not useful for severe and critical COVID-19 Pneumonia”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 6 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Centro Medico ABC

Sponsor type

University, hospital or other

Conditions

Covid-19

Interventions

Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients; Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients

Participants

6

Sites

1

Countries

Mexico

Trials that died the same way

• Pedicle Osteotomy for Stenosis Trial
  “In light of the ongoing COVID-19 pandemic and its impact on clinical trials” (56% match in meaning)
• Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection
  “lack of Covid-19 patients” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.